Related references
Note: Only part of the references are listed.Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world
Linda Henry et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
Maria Stepanova et al.
HEPATOLOGY COMMUNICATIONS (2022)
De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors
Javier Tejedor-Tejada et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
The Utility of Assessing Liver Allograft Fibrosis and Steatosis PosteLiver Transplantation Using Transient Elastography With Controlled Attenuation Parameter
Maneerat Chayanupatkul et al.
TRANSPLANTATION PROCEEDINGS (2021)
Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study
Jakob Van Herck et al.
TRANSPLANTATION PROCEEDINGS (2021)
New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore
Xiao Ying Li et al.
ANNALS ACADEMY OF MEDICINE SINGAPORE (2021)
Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation
Irena Mikova et al.
TRANSPLANTATION (2020)
Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis
Ahad Eshraghian et al.
HPB (2020)
Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graft
Eva M. Dobrindt et al.
CLINICAL TRANSPLANTATION (2020)
Hepatic steatosis and liver fat contents in liver transplant recipients are associated with serum adipokines and insulin resistance
Ahad Eshraghian et al.
SCIENTIFIC REPORTS (2020)
Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation
Hisamitsu Miyaaki et al.
TRANSPLANTATION (2019)
Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation
Praveena Narayanan et al.
TRANSPLANTATION (2019)
Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation
Kazuaki Tokodai et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients
Ondrej Seda et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis
Naba Saeed et al.
TRANSPLANTATION (2019)
Incidence of Recurrent NASH-Related Allograft Cirrhosis
Shelly Kakar et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis
Zita Galvin et al.
LIVER TRANSPLANTATION (2019)
Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients
Hyeyoung Kim et al.
HEPATOLOGY RESEARCH (2018)
PNPLA3 as a liver steatosis risk factor following living-donor liver transplantation for hepatitis C
Hisamitsu Miyaaki et al.
HEPATOLOGY RESEARCH (2018)
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients
G. Losurdo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study
Pavel Trunecka et al.
DIGESTIVE AND LIVER DISEASE (2018)
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients
Stefano Gitto et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Nonalcoholic steatohepatitis in posttransplantation liver: Review article
Antonio Ricardo Cardia Ferraz de Andrade et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2018)
Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation
Achuthan Sourianarayanane et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study
Michael Charlton et al.
TRANSPLANTATION (2017)
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
Chandra Bhati et al.
TRANSPLANTATION (2017)
New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
Antonio R. Andrade et al.
ANNALS OF HEPATOLOGY (2017)
Prevalence and Risk Factors of Steatosis After Liver Transplantation and Patient Outcomes
Irena Hejlova et al.
LIVER TRANSPLANTATION (2016)
Histologically proven non- alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation
Hyeyoung Kim et al.
CLINICAL TRANSPLANTATION (2014)
Recurrent or De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation: Natural History Based on Liver Biopsy Analysis
Melanie Vallin et al.
LIVER TRANSPLANTATION (2014)
The Portrait of an Adult Liver Transplant Recipient in the United States From 1987 to 2013
Maria Stepanova et al.
JAMA INTERNAL MEDICINE (2014)
Patatin-Like Phospholipase Domain-Containing Protein 3 rs738409-G in Recipients of Liver Transplants Is a Risk Factor for Graft Steatosis
Armin Finkenstedt et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation
Martin F. Sprinzl et al.
TRANSPLANT INTERNATIONAL (2013)
Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome
Mazen M. El Atrache et al.
CLINICAL TRANSPLANTATION (2012)
NAFLD Recurrence in Liver Transplant Recipients
Parul Dureja et al.
TRANSPLANTATION (2011)
Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of Seed and Soil
Jerome Dumortier et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
Kanthi Yalamanchili et al.
LIVER TRANSPLANTATION (2010)
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
Shahid M. Malik et al.
LIVER TRANSPLANTATION (2009)
Outcomes of Liver Transplantation in Patients with Cirrhosis due to Nonalcoholic Steatohepatitis Versus Patients with Cirrhosis due to Alcoholic Liver Disease
Vishal Bhagat et al.
LIVER TRANSPLANTATION (2009)
de novo nonalcoholic fatty liver disease after liver transplantation
Suk Seo et al.
LIVER TRANSPLANTATION (2007)
Prevalence and clinical associations of posttransplant fatty liver disease
Lee Guan Lim et al.
LIVER INTERNATIONAL (2007)
Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy
DS Sutedja et al.
TRANSPLANTATION PROCEEDINGS (2004)
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
J Ong et al.
LIVER TRANSPLANTATION (2001)
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
M Charlton et al.
LIVER TRANSPLANTATION (2001)
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
MJ Contos et al.
LIVER TRANSPLANTATION (2001)
Share Paper
